Keytruda

Product Description

Generic name: PEMBROLIZUMAB
Full name: KEYTRUDA **0MG/4ML CONC FOR SOL FOR INF VIAL (1) â–¼
Manufacturer: MERCK SHARP & DOHME LTD
Storage: Fridge 
Temperature: **8 degrees 

KEYTRUDA is indicated for the adjuvant treatment of adult and pediatric (*2 years and older) patients with stage IIB, IIC, or III melanoma following complete resection.

Pembrolizumab (brand name: Keytruda) is a prescription immunotherapy drug used to treat many different types of cancer in adults and children. Adult uses include:

melanoma, squamous cell carcinoma, or Merkel cell carcinoma (types of serious skin cancer)
lung cancer, Non-Small Cell Lung Cancer (NSCLC)
head and neck squamous cell cancer
classical Hodgkin lymphoma (type of blood cancer))
primary mediastinal large B-cell lymphoma
cancer of the kidney, bladder, and urinary tract
liver cancer
biliary tract cancer
colorectal (colon) cancer
cancer of the cervix
endometrial cancer
advanced stomach cancer
esophageal cancer
triple negative breast cancer
Microsatellite Instability-High or Mismatch Repair Deficient Cancer (cancer that affects the proper repair of DNA inside the cell)
Tumor Mutational Burden-High (TMB-H) Cancer (cancers that have many gene mutations)
cancers that laboratory testing proves to have certain specific DNA mutations